Hubbard Cristin — SEC Form 4 filings

SEC reporting owner CIK 2021836. 6 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-05-22 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BIOMARIN PHARMACEUTICAL INC (BMRN)EVP, Chief Commercial Officer61 leg · 273 sh · $17,72311

Form 4 filings — Hubbard Cristin

FiledFormIssuerReported transactionsSource
2026-05-214BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 2,318 @ $50.20EDGAR
2026-03-184BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 15,410 @ $0 · Tax withholding (F): 1,245 @ $56.05 · Grant/award (A): 36,680 (derivative) @ $0EDGAR
2025-05-224BIOMARIN PHARMACEUTICAL INC (BMRN)Tax withholding (F): 2,155 @ $59.93EDGAR
2025-05-064BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 273 @ $54.14 · Sale (S): 273 @ $64.92EDGAR
2025-03-184BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 13,310 @ $0 · Grant/award (A): 30,880 (derivative) @ $0EDGAR
2024-05-224BIOMARIN PHARMACEUTICAL INC (BMRN)Grant/award (A): 14,690 @ $0 · Grant/award (A): 4,700 @ $0 · Grant/award (A): 33,520 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2021836 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →